Innokas Medical has entered into R&D agreements with two healthcare technology companies operating in central Europe.
Both agreements involve new customers for Innokas, and represent an important step in the company’s growth and internationalization.
Under the first agreement, which was signed with a company headquartered in France, Innokas will develop a a patient monitoring device. In the future it will be required to verify that prescribed treatment has been used when public funding has been provided.
The second agreement is with a company that operates in the medical sector in central Europe and concentrates on non-invasive treatments. The project will start with a feasibility study to verify the customer’s concept of a new cooling system using thermal and hydraulic simulation models and a prototype of the system.